
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy... Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product candidate, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System, or Melphalan/HDS, is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.78 | -4.79115479115 | 16.28 | 16.43 | 14.85 | 275059 | 16.00586322 | CS |
4 | -0.62 | -3.84615384615 | 16.12 | 16.97 | 14.85 | 355280 | 15.98387339 | CS |
12 | 4.28 | 38.1461675579 | 11.22 | 16.97 | 10.75 | 387542 | 13.65613751 | CS |
26 | 7.62 | 96.7005076142 | 7.88 | 16.97 | 7.83 | 379363 | 11.61710162 | CS |
52 | 11.38 | 276.213592233 | 4.12 | 16.97 | 3.7 | 313387 | 9.59550233 | CS |
156 | 9.04 | 139.938080495 | 6.46 | 16.97 | 2.25 | 349240 | 6.43487335 | CS |
260 | 11.73 | 311.140583554 | 3.77 | 25.18 | 2.25 | 253291 | 7.33370022 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.